share_log

坎托菲茨杰拉德公司:重申Taysha Gene Therapies(TSHA.US)评级,由增持调整至增持评级, 目标价7.00美元。

Zhitong Finance ·  May 15 08:15

坎托菲茨杰拉德公司:重申Taysha Gene Therapies(TSHA.US)评级,由增持调整至增持评级, 目标价7.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment